Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Jan 4;4(2):e00213.
doi: 10.1002/edm2.213. eCollection 2021 Apr.

Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post-hoc analysis of a randomized crossover trial

Affiliations
Randomized Controlled Trial

Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post-hoc analysis of a randomized crossover trial

Naba Al-Sari et al. Endocrinol Diabetes Metab. .

Abstract

Aims: Lipid metabolism might be compromised in type 1 diabetes, and the understanding of lipid physiology is critically important. This study aimed to compare the change in plasma lipid concentrations during carbohydrate dietary changes in individuals with type 1 diabetes and identify links to early-stage dyslipidaemia. We hypothesized that (1) the lipidomic profiles after ingesting low or high carbohydrate diet for 12 weeks would be different; and (2) specific annotated lipid species could have significant associations with metabolic outcomes.

Methods: Ten adults with type 1 diabetes (mean ± SD: age 43.6 ± 13.8 years, diabetes duration 24.5 ± 13.4 years, BMI 24.9 ± 2.1 kg/m2, HbA1c 57.6 ± 2.6 mmol/mol) using insulin pumps participated in a randomized 2-period crossover study with a 12-week intervention period of low carbohydrate diet (< 100 g carbohydrates/day) or high carbohydrate diet (> 250 g carbohydrates/day), respectively, separated by a 12-week washout period. A large-scale non-targeted lipidomics was performed with mass spectrometry in fasting plasma samples obtained before and after each diet intervention. Longitudinal lipid levels were analysed using linear mixed-effects models.

Results: In total, 289 lipid species were identified from 14 major lipid classes. Comparing the two diets, 11 lipid species belonging to sphingomyelins, phosphatidylcholines and LPC(O-16:0) were changed. All the 11 lipid species were significantly elevated during low carbohydrate diet. Two lipid species were most differentiated between diets, namely SM(d36:1) (β ± SE: 1.44 ± 0.28, FDR = 0.010) and PC(P-36:4)/PC(O-36:5) (β ± SE: 1.34 ± 0.25, FDR = 0.009) species. Polyunsaturated PC(35:4) was inversely associated with BMI and positively associated with HDL cholesterol (p < .001).

Conclusion: Lipidome-wide outcome analysis of a randomized crossover trial of individuals with type 1 diabetes following a low carbohydrate diet showed an increase in sphingomyelins and phosphatidylcholines which are thought to reduce dyslipidaemia. The polyunsaturated phosphatidylcholine 35:4 was inversely associated with BMI and positively associated with HDL cholesterol (p < .001). Results from this study warrant for more investigation on the long-term effect of single lipid species in type 1 diabetes.

Trial registration: ClinicalTrials.gov NCT02888691.

Keywords: cardiovascular disease; dyslipidaemia; lipidomics; low carbohydrate diet; randomized trial; type 1 diabetes.

PubMed Disclaimer

Conflict of interest statement

None of the investigators has personal interests in the conduct or the outcomes of the study.

Figures

Figure 1
Figure 1
Jittered box plots of pre‐post lipid levels comparisons of PC(35:4) in each diet intervention and association with BMI and HDL cholesterol. PC(35:4): (β ± SE: 1.04 ± 0.28, p = .043) was elevated during LCD (a) and inversely associated with BMI (b) and positively associated with HDL cholesterol (c). HB: High carbohydrate diet at baseline, HF: High carbohydrate diet at follow‐up, LB: Low carbohydrate diet at baseline, LF: Low carbohydrate diet at follow‐up

Similar articles

Cited by

References

    1. Melendez‐Ramirez LY, Richards RJ, Cefalu WT. Complications of type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39(3):625‐640. - PubMed
    1. Ahola AJ, Forsblom C, Harjutsalo V, Groop P. Dietary carbohydrate intake and cardio‐metabolic risk factors in type 1 diabetes. Diabetes Res Clin Pract. 2019;155(2019):107818. - PubMed
    1. Schofield JD, Liu Y, Rao‐Balakrishna P, Mlik RA, Soran H. diabetes dyslipidemia. Diabetes Ther. 2016;7(2):203‐219. - PMC - PubMed
    1. Lopes SA, Fumani C, Jornayvaz FR, Philippe J, Gastaldi G. (2018) Dyslipidemia management in patients with type 1 diabetes. Rev Med Suisse 14(609), 1118‐1122. - PubMed
    1. Vergès B. Dyslipidemia in type 1 diabetes: a masked danger. Trends Endocrinol Metab. 2020;31(6):422‐434. - PubMed

Publication types

Associated data